Mohanty Aditya P. Insider Trades

Insider Trading History

Track insider trading activity for Mohanty Aditya P.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Biora Therapeutics
Biora Therapeutics BIOR
Chief Executive Officer
Holding Value $323k 1,468,609 shares
Last Trade
Aug 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$472k 70,883 shares
$6.66
$0.22
Progenity
Progenity PROG
Chief Executive Officer
Holding Value $1.3M 1,468,609 shares
Last Trade
Aug 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$62.7k 70,883 shares
$0.88
$0.88
Biora Therapeutics
Biora Therapeutics BIOR
Chief Executive Officer
Holding Value $339k 1,539,492 shares
Last Trade
Feb 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.63M 819,000 shares
$8.09
$0.22
Biora Therapeutics
Biora Therapeutics BIOR
Chief Executive Officer
Holding Value $159k 720,492 shares
Last Trade
Aug 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.6M 559,450 shares
$31.40
$0.22
Biora Therapeutics
Biora Therapeutics BIOR
Chief Executive Officer
Holding Value $35.4k 161,042 shares
Last Trade
Aug 15, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.7M 117,881 shares
$31.40
$0.22
OncoCyte
OncoCyte 0KCC.L
Director
Holding Value $288k 45,000 shares
Last Trade
Jul 17, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$6.41
OncoCyte
OncoCyte 0KCC.L
Director
Holding Value $216k 33,750 shares
Last Trade
Feb 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$6.41
Eterna Therapeutics
Eterna Therapeutics ERNA
Co-chief Executive Officer
Holding Value $269k 32,813 shares
Last Trade
Jul 10, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.4M 4,687 shares
$2,652.00
$8.19
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Co-chief Executive Officer
Holding Value $39.7k 32,813 shares
Last Trade
Jul 10, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.58k 4,687 shares
$2.04
$1.21
Eterna Therapeutics
Eterna Therapeutics ERNA
Co-chief Executive Officer
Holding Value $830k 101,384 shares
Last Trade
Jul 10, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.3M 1,621 shares
$2,652.00
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Co-chief Executive Officer
Holding Value $844k 103,005 shares
Last Trade
Jul 10, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.4M 4,687 shares
$2,652.00
$8.19
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Co-chief Executive Officer
Holding Value $125k 103,005 shares
Last Trade
Jul 10, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.58k 4,687 shares
$2.04
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Co-chief Executive Officer
Holding Value $123k 101,384 shares
Last Trade
Jul 10, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.57k 1,621 shares
$2.20
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Co-chief Executive Officer
Holding Value $45.4k 37,500 shares
Last Trade
Apr 10, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.8k 4,688 shares
$2.31
$1.21
Eterna Therapeutics
Eterna Therapeutics ERNA
Co-chief Executive Officer
Holding Value $805k 98,318 shares
Last Trade
Apr 10, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.44M 1,622 shares
$3,354.00
$8.19
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Co-chief Executive Officer
Holding Value $121k 99,940 shares
Last Trade
Apr 10, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.8k 4,688 shares
$2.31
$1.21
Lineage Cell Therapeutics
Lineage Cell Therapeutics LCTX
Co-chief Executive Officer
Holding Value $119k 98,318 shares
Last Trade
Apr 10, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.04k 1,622 shares
$2.49
$1.21
Eterna Therapeutics
Eterna Therapeutics ERNA
Co-chief Executive Officer
Holding Value $819k 99,940 shares
Last Trade
Apr 10, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.7M 4,688 shares
$3,354.00
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Co-chief Executive Officer
Holding Value $307k 37,500 shares
Last Trade
Apr 10, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.7M 4,688 shares
$3,354.00
$8.19
Eterna Therapeutics
Eterna Therapeutics ERNA
Co-chief Executive Officer
Holding Value $1.64M 200,000 shares
Last Trade
Mar 15, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$712M 200,000 shares
$3,558.00
$8.19

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up